Could This Be Eli Lilly's Next Blockbuster Drug?

[cafead]

via

• Mirikizumab could be used by tens of thousands of patients if approved by the U.S. Food and Drug Administration.
• An ulcerative colitis indication could generate $800 million in annual sales for Eli Lilly in the U.S. alone.
• Eli Lilly still looks like it could be a buy for growth investors.

article source